BSX
NYSEBoston Scientific Corporation
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 17 recent filings. 13 other (grants, option exercises, gifts, tax withholding) are listed below but excluded from buy/sell flow.
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Monson Jonathan EVP and CFO | Option exercise | 2.09K | $0.00 | — | 2026-07-01 |
Monson Jonathan EVP and CFO | Tax withholding | 1.01K | $43.06 | $43,490.60 | 2026-07-01 |
Monson Jonathan EVP and CFO | Option exercise | 2.09K | $0.00 | — | 2026-07-01 |
Mahoney Michael F Director, Chairman, President & CEO | Gift | 386.76K | $0.00 | — | 2026-05-28 |
Pegus Cheryl Director | Buy (open market) | 1.77K | $56.49 | $99,987.30 | 2026-05-20 |
LUDWIG EDWARD J Director | Buy (open market) | 3.58K | $56.68 | $202,914.40 | 2026-05-20 |
Habiger David C Director | Buy (open market) | 2.2K | $56.95 | $125,279.22 | 2026-05-19 |
Habiger David C Director | Buy (open market) | 2.25K | $55.92 | $125,818.88 | 2026-05-20 |
Zane Ellen M Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
WICHMANN DAVID S Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
Weber Christophe Pierre Director | Grant / award | 1.77K | $0.00 | — | 2026-05-07 |
Weber Christophe Pierre Director | Grant / award | 1.14K | $0.00 | — | 2026-05-07 |
Weber Christophe Pierre Director | Grant / award | 2.66K | $0.00 | — | 2026-05-07 |
Smith Cathy R Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
Smith Cathy R Director | Grant / award | 2.21K | $0.00 | — | 2026-05-07 |
Pegus Cheryl Director | Grant / award | 3.8K | $0.00 | — | 2026-05-07 |
Pegus Cheryl Director | Grant / award | 1.28K | $0.00 | — | 2026-05-07 |
Source: SEC EDGAR Forms 4/4A (CIK 885725). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
$BSX going to be taken private at $87 a share. I know nothing. Hologic, though…
$DGXX these guys sure love moving in tandem … and then there’s $BSX .. the only one red today
$BSX we were green for a minute I saw it!
$BSX Price action is really odd.
$BSX fighting back like a champ 🏆
$BSX we will push towards $50 in August folks, the worse is behind us now. Next earnings we will be at $55+ and then close out the year around $62-$65. Next year we see $75+ again but I want $85‼️
$BSX can we flip green?
$BSX big boys averaged down and eliminated gap. Largest jump in share ownership since 2022.
$BSX AITX's RIO Mini, ROSA, and SARA platform continues gaining traction with customers looking for AI-driven security solutions.
$BSX so, apparently a bunch of downgrades were not enough. Now we're going to have another round of downgrades. But the stock dumped today because semis bounced. Always watch semis - if they're down, BSX is green.
$BSX threw ever including the kitchen sink out in this Q re, at 48 to 50 does it get a M&A bid for 68 to 74 ? where does the PEN deal stand, surely those shareholders can’t be excited, deal was announced BSX around a $100, fixed amount of shares, half the economic value …
$BSX ppl need to chill out, for the last month or so we were oscillating between 42-44, now we’re at 45 and hopefully staying there, they can slash guidance more for all i care this stock is solid and at an ultra bargain
Latest news
BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook
Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls
Argus Downgrades Boston Scientific to Hold From Buy
Here Are Friday’s Top Wall Street Analyst Research Calls: Blackstone Mortgage, Boston Scientific, Edison International, Ford, GoDaddy, International Paper, Roblox, Saia, and More
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says
Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says
Leerink Partners Adjusts Boston Scientific Price Target to $60 From $74, Maintains Outperform Rating
Wells Fargo Adjusts Boston Scientific Price Target to $50 From $55, Maintains Equal Weight Rating
BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.